Table 1.
Authors | Patient age (years) |
Tumor size (cm) | FIGO stage |
Pathology | Patient outcomes | |
---|---|---|---|---|---|---|
Carcinoma | Sarcoma | |||||
Hanada et al. [10] | 75 | 21 | N/A | Squamous cell carcinoma | Malignant fibrous histiocytoma (myxoid variant) | NED, for 21 months |
Arora and Haldane [4] | 78 | 23 | N/A | Adenocarcinoma | No definite differentiation∗ | N/A |
Cabibi et al. [15] | 69 | 27 | N/A | Squamous cell carcinoma | No definite differentiation∗ | N/A |
Allam-Nandyala et al. [6] | 55 | 11.8 | N/A | Squamous cell carcinoma | Osteosarcoma | DOD, after 5 months |
Savitchi and Rao [9] | 58 | 30 | IIIB | Squamous cell carcinoma | Malignant fibrous histiocytoma | DOD, after 5 months |
Current case | 65 | 17 | At least IIIC | Squamous cell carcinoma | Leiomyosarcoma | DOC, after 1 month |
N/A, not available; NED, no evidence of disease; DOD, dead of disease; DOC, dead of unrelated cause. ∗Focally positive for smooth muscle actin.